Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;52(2):561-578.
doi: 10.1111/1475-6773.12539.

Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services

Rebecca P Barclay  1 , Robert B Penfold  2 , Donna Sullivan  3 , Lauren Boydston  4 , Julia Wignall  1 , Robert J Hilt  1
Affiliations

Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services

Rebecca P Barclay et al. Health Serv Res. 2017 Apr.

Abstract

Objective: To learn if a quality of care Medicaid child psychiatric consultation service implemented in three different steps was linked to changes in statewide child antipsychotic utilization.

Data sources/study setting: Washington State child psychiatry consultation program primary data and Medicaid pharmacy division antipsychotic utilization secondary data from July 1, 2006, through December 31, 2013.

Study design: Observational study in which consult program data were analyzed with a time series analysis of statewide antipsychotic utilization.

Data collection/extraction methods: All consultation program database information involving antipsychotics was compared to Medicaid pharmacy division database information involving antipsychotic utilization.

Principal findings: Washington State's total child Medicaid antipsychotic utilization fell from 0.51 to 0.25 percent. The monthly prevalence of use fell by a mean of 0.022 per thousand per month following the initiation of elective consults (p = .004), by 0.065 following the initiation of age/dose triggered mandatory reviews (p < .001), then by another 0.022 following the initiation of two or more concurrent antipsychotic mandatory reviews (p = .001). High-dose antipsychotic use fell by 57.8 percent in children 6- to 12-year old and fell by 52.1 percent in teens.

Conclusions: Statewide antipsychotic prescribing for Medicaid clients fell significantly at different rates following each implementation step of a multilevel consultation and best-practice education service.

Keywords: Antipsychotic agents; Medicaid; child and adolescent psychiatry; outcome assessment (health care); referral and consultation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ratio of Atypical Antipsychotic Users/Child Medicaid Enrollees Decreased after Implementation of Each Review Phase
Figure 2
Figure 2
Children Receiving Antipsychotics with Dose > Maximum Decreased after Initiation of Mandatory Antipsychotic Reviews

  1. Note. *Shaded bar represents 9‐month period from start of reviews until change in use of antipsychotic at dose > maximum allowed stabilized.

See this image and copyright information in PMC

References

    1. “Achieving the Promise: Transforming Mental Health Care in America.” 2013. President's New Freedom Commission on Mental Health; Published July [accessed on December 16, 2015]. Available at http://govinfo.library.unt.edu/mentalhealthcommission/reports/FinalRepor...
    1. Alexander, G. C. , Gallagher S. A., Mascola A., Moloney R. M., and Stafford R. S.. 2011. “Increasing Off‐Label Use of Antipsychotic Medications in the United States, 1995‐2008.” Pharmacoepidemiology and Drug Safety 20: 177–84. - PMC - PubMed
    1. Andrade, S. E. , Lo J. C., Roblin D., and Fouayzi H.. 2011. “Antipsychotic Medication Use among Children and Risk of Diabetes Mellitus.” Pediatrics 128 (6): 1135–41. - PubMed
    1. Burcu, M. , Zito J. M., Ibe A., and Safer D.. 2014. “Atypical Antipsychotic Use Among Medicaid‐Insured Children and Adolescents: Duration, Safety, and Monitoring Implications.” Journal of Child and Adolescent Psychopharmacology 24 (3): 112–9. - PubMed
    1. Child and Family Service Improvement and Innovation Act . 2011. (P.L. 112‐34). [accessed on May 7, 2015]. Available at http://www.gpo.gov/fdsys/pkg/PLAW-112publ34/content-detail.html

Publication types

Substances

LinkOut - more resources